DD147537A5 - Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen - Google Patents

Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen Download PDF

Info

Publication number
DD147537A5
DD147537A5 DD79217246A DD21724679A DD147537A5 DD 147537 A5 DD147537 A5 DD 147537A5 DD 79217246 A DD79217246 A DD 79217246A DD 21724679 A DD21724679 A DD 21724679A DD 147537 A5 DD147537 A5 DD 147537A5
Authority
DD
German Democratic Republic
Prior art keywords
methoxyphenyl
piperidine
formula
group
propyl
Prior art date
Application number
DD79217246A
Other languages
German (de)
English (en)
Inventor
Dennis M Zimmermann
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD147537A5 publication Critical patent/DD147537A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD79217246A 1978-11-29 1979-11-29 Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen DD147537A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/965,137 US4284635A (en) 1978-11-29 1978-11-29 Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines

Publications (1)

Publication Number Publication Date
DD147537A5 true DD147537A5 (de) 1981-04-08

Family

ID=25509504

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79217246A DD147537A5 (de) 1978-11-29 1979-11-29 Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen

Country Status (26)

Country Link
US (1) US4284635A (ja)
EP (1) EP0013078A3 (ja)
JP (1) JPS5573657A (ja)
KR (1) KR830001214A (ja)
AR (1) AR224138A1 (ja)
AT (1) ATA750879A (ja)
AU (1) AU529136B2 (ja)
BE (1) BE880220A (ja)
CA (1) CA1121357A (ja)
DD (1) DD147537A5 (ja)
DK (1) DK504979A (ja)
EG (1) EG14137A (ja)
ES (2) ES486425A0 (ja)
FI (1) FI793663A (ja)
FR (2) FR2442836A1 (ja)
GB (1) GB2038812B (ja)
GR (1) GR72292B (ja)
HU (1) HU178532B (ja)
IL (1) IL58793A0 (ja)
IT (1) IT1126406B (ja)
LU (1) LU81923A1 (ja)
PH (1) PH15420A (ja)
PL (1) PL123672B1 (ja)
PT (1) PT70486A (ja)
SU (1) SU967275A3 (ja)
ZA (1) ZA796336B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212183A (en) * 1981-11-14 1993-05-18 Basf Aktiengesellschaft 4-(p-tert.-butylphenyl)-3-methylpiperidines substituted at the nitrogen, their quaternary salts and their use as fungicides
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
ZW10287A1 (en) * 1986-07-15 1988-01-13 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
CA1337418C (en) * 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
US2956058A (en) * 1957-08-19 1960-10-11 Lilly Co Eli Novel substituted piperidines and pyrrolidines
US3043845A (en) * 1958-12-29 1962-07-10 Abbott Lab Phenylmethylpiperidine derivatives
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
NL123743C (ja) * 1963-09-18
BE720927A (ja) * 1967-09-27 1969-03-03
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives
GB1403942A (en) * 1973-04-05 1975-08-28 Ciba Geigy Ag Piperidine derivatives
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes
ZA777356B (en) * 1976-12-17 1979-01-31 Rohm & Haas Arthropod repellents

Also Published As

Publication number Publication date
ZA796336B (en) 1981-06-24
EG14137A (en) 1983-09-30
BE880220A (fr) 1980-05-23
EP0013078A3 (en) 1980-10-01
FR2442836A1 (fr) 1980-06-27
GB2038812B (en) 1983-01-06
PT70486A (en) 1979-12-01
EP0013078A2 (en) 1980-07-09
ES8101551A1 (es) 1980-12-16
GR72292B (ja) 1983-10-17
PL123672B1 (en) 1982-11-30
AU5310079A (en) 1980-05-29
IT7927614A0 (it) 1979-11-27
JPS5573657A (en) 1980-06-03
LU81923A1 (fr) 1980-04-22
HU178532B (en) 1982-05-28
AR224138A1 (es) 1981-10-30
PH15420A (en) 1983-01-07
IL58793A0 (en) 1980-02-29
CA1121357A (en) 1982-04-06
ATA750879A (de) 1983-03-15
FR2442836B1 (ja) 1983-07-29
KR830001214A (ko) 1983-04-29
IT1126406B (it) 1986-05-21
ES8200664A1 (es) 1981-11-16
FI793663A (fi) 1980-05-30
FR2453154A1 (fr) 1980-10-31
PL219885A1 (ja) 1980-12-01
FR2453154B1 (ja) 1983-05-27
SU967275A3 (ru) 1982-10-15
ES486425A0 (es) 1980-12-16
US4284635A (en) 1981-08-18
ES493915A0 (es) 1981-11-16
DK504979A (da) 1980-05-30
AU529136B2 (en) 1983-05-26
GB2038812A (en) 1980-07-30

Similar Documents

Publication Publication Date Title
DE60030883T2 (de) Verfahren zur herstellung von alfentanil, sufentanil und remifentanil
DE29724281U1 (de) 4-Phenylpiperidin-Verbindungen
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
CH625787A5 (ja)
DE2952213A1 (de) Phenoxyphenylpiperidine
DE2002840A1 (de) 2,3,5-trisubstit,-2'-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung
DE2407115A1 (de) Neue 1,4-dihydropyridinderivate
DE2657978C3 (de) Linksdrehende Enantiomere und Racemate von Trifluormethylthio(und -sulfonyl)cyproheptadinderivaten, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3125471A1 (de) "piperazinderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten"
EP0048218A1 (de) N-Oxide von N-Oxacyclyl-alkyl-piperidinen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
DE2719211C3 (de) 1-(2-Phenylamino-äthyl)-4-(N-phenyl-N-propionylamino)-piperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2524054A1 (de) 1-cycloalkylmethyl-3a-(substituiertes-phenyl)-decahydroisochinoline
DE2628570B2 (ja)
DE2524053A1 (de) 1-aethyl-3a-substituiertes-phenyl- decahydroisochinoline
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0233483B1 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
DD141156A5 (de) Verfahren zur herstellung von 4a-aryl-octahydro-1h-2-pyrindinen
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE3028064C2 (ja)
DE2657950A1 (de) Trifluormethylthioderivate von cyproheptadin
DE2528194C2 (de) Benzhydryloxyäthylamin-Derivate, deren Salze, Verfahren zur Herstellung derselben und solche enthaltende Arzneimittel
DE2912026C2 (ja)
EP0013424B1 (de) Spiro(dibenz(b,f)thiepin-piperidine), Zwischenprodukte zu ihrer Herstellung und sie enthaltende Arzneimittel
US4228288A (en) Certain substituted 3,4,5,6-tetrahydropyridinium salt intermediates
DE1931487C3 (de) In 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo eckige Klammer auf b,e eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu diazepin-11 -one und Verfahren zu ihrer Herstellung